Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects (ARAMIA)

This study has been terminated.
(Difficulties in completing the required sample size)
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Fundación Cardiovascular de Colombia
ClinicalTrials.gov Identifier:
NCT00319202
First received: April 26, 2006
Last updated: November 2, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2012
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)